Joong-Sik Do
Chief Executive Officer at INCON CO.,LTD.
Network origin in Joong-Sik Do first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Electronics/Appliances | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joong-Sik Do via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SBI HOLDINGS, INC. | Financial Conglomerates | Director/Board Member | |
| GEMVAXLINK CO., LTD. | Apparel/Footwear Retail | Comptroller/Controller/Auditor | |
| KBIO COMPANY INC. | Medical Distributors | Director/Board Member | |
| University of Illinois | College/University | Doctorate Degree | |
| DAEA TI CO., LTD. | Trucks/Construction/Farm Machinery | Director/Board Member | |
| JOKWANG ILI CO., LTD. | Industrial Machinery | Director/Board Member | |
| Waseda University | College/University | Graduate Degree | |
| Seoul National University | College/University | Graduate Degree | |
| Hanyang University | College/University | Masters Business Admin | |
| Korea University | College/University | Graduate Degree Undergraduate Degree | |
| Sungkyunkwan University | College/University | Doctorate Degree | |
SBI Investment Korea Co., Ltd. (Private Equity)
 SBI Investment Korea Co., Ltd. (Private Equity) Investment ManagersFinance SBI Investment Korea Co.,Ltd.(Private Equity) (SBI Investment Korea) is a private equity & venture capital firm founded in 1986. The firm is headquartered in Seoul, South Korea. | Investment Managers | Chief Executive Officer | |
SBI Korea Holdings Co., Ltd.
 SBI Korea Holdings Co., Ltd. Financial ConglomeratesFinance Part of SBI Holdings, Inc., SBI Korea Holdings Co., Ltd. is an investment holding South Korean company. The company is based in Seoul, South Korea. Yoshimi Takahashi has been the CEO of the company since 2002. | Financial Conglomerates | Chief Executive Officer | |
| Catholic University of Korea | College/University | Doctorate Degree | |
NEOBIOTECH Co., Ltd.
 NEOBIOTECH Co., Ltd. Medical SpecialtiesHealth Technology NEOBIOTECH Co., Ltd. is a holding company, which manufactures dental implants. Its products include peri-implantitis solutions, sinus and remover kits, and Neo CMI implants. The company was founded on July 20, 2000 and is headquartered in Seoul, South Korea. | Medical Specialties | Chief Executive Officer | |
| SBI INVESTMENT KOREA CO., LTD. | Investment Managers | Chief Executive Officer | |
| Finance All Solutions Co. Ltd. | Director/Board Member | ||
How Asset Management
 How Asset Management Real Estate DevelopmentFinance How Asset Management offers real estate management services. The company was founded on June 27, 2008 and is headquartered in Seoul, South Korea. | Real Estate Development | Director/Board Member | |
Atrin Pharmaceuticals LLC
 Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member | |
| NDFOS CO., LTD. | Containers/Packaging | Director/Board Member | |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| South Korea | 19 |
| United States | 5 |
| Japan | 3 |
| Canada | 2 |
Sectoral
| Consumer Services | 9 |
| Finance | 8 |
| Health Technology | 5 |
| Producer Manufacturing | 3 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 24 |
| Chief Executive Officer | 8 |
| Independent Dir/Board Member | 7 |
| Graduate Degree | 3 |
| Doctorate Degree | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Yoshimi Takahashi | 11 |
| Benjamin R. Cowen | 6 |
| Yoon-Geun Ham | 4 |
| Young-Goo Heo | 3 |
| Do-Heon Ban | 3 |
| Seong-Chul Cho | 3 |
| Kyung-Jae Yoo | 2 |
| Young-Bum Cho | 2 |
| Dong-Won Kim | 1 |
| Ki-Lim Han | 1 |
| Jong-Min Lee | 1 |
| Ju-Hyung Lee | 1 |
- Stock Market
- Insiders
- Joong-Sik Do
- Company connections
